The U.S. Army has developed a vaccine it says may provide protection against all COVID-19 variants.
The Walter Reed Army Institute of Research (WRAIR) developed a 24-sided object to which it attached various protein spikes from coronavirus variants. The vaccine has completed phase 1 trials, but researchers have yet to test it against the omicron variant, an Army spokesman told Fox News.
Researchers received a sample in early 2020 and focused efforts on developing a vaccine that would work against potential variants. Two years later, the initial results show promise.
FILE – Staff Sgt. Travis Snyder, left, receives the first dose of the Pfizer COVID-19 vaccine given at Madigan Army Medical Center at Joint Base Lewis-McChord in Washington state, Dec. 16, 2020, south of Seattle. The Army says 98% of its active duty force had gotten at least one dose of the mandatory coronavirus vaccine as of this week’s deadline for the shots. (AP Photo/Ted S. Warren, File)
The phase 1 human trials commenced April 2021. Scientists hailed the early data as encouraging and will publish final phase 1 study results once they complete the analysis.
COVID-19: KEY STEPS TO TAKE IF YOU TEST POSITIVE
The theory behind the development of the Spike Ferritin Nanoparticle Platform (SpFN) vaccine posits that introducing multiple copies of spike proteins in an “ordered fashion” may prove key to creating a “potent and broad response.”
Part of the Walter Reed Army Medical…
